Malignant potential of small oncocytic follicular carcinoma/Hürthle cell carcinoma: An institutional experience

Histopathology

Volumn 63, Issue 4, 2013, Pages 568-573

  Samulski, Teresa Danielle ^a   Bai, Shuting ^b   Livolsi, Virginia A ^a   Montone, Kathleen ^a   Baloch, Zubair ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

H rthle cell carcinoma; Size; Thyroid

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SIZE; CLINICAL FEATURE; DISTANT METASTASIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; ONCOCYTIC FOLLICULAR CARCINOMA; PRIORITY JOURNAL; RARE DISEASE; THYROID CANCER;

HÜRTHLE CELL CARCINOMA; SIZE; THYROID;

FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS;

EID: 84884717619     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12206     Document Type: Article

References (15)

1. Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch. Pathol. Lab. Med. 2008; 132; 1241-1250.
2. Stojadinovic A, Hoos A, Ghossein RA et al. Hurthle cell carcinoma: a 60-year experience. Ann. Surg. Oncol. 2002; 9; 197-203.
3. Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hurthle cell cancer. World J. Surg. 2004; 28; 1266-1270.
4. Zhang YW, Greenblatt DY, Repplinger D et al. Older age and larger tumor size predict malignancy in Hurthle cell neoplasms of the thyroid. Ann. Surg. Oncol. 2008; 15; 2842-2846.
5. Lopez-Penabad L, Chiu AC, Hoff AO et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 2003; 97; 1186-1194.
6. Mills SC, Haq M, Smellie WJ, Harmer C. Hurthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur. J. Surg. Oncol. 2009; 35; 230-234.
7. Guerrero MA, Suh I, Vriens MR et al. Age and tumor size predicts lymph node involvement in Hurthle cell carcinoma. J. Cancer 2010; 1; 23-26.
8. Sippel RS, Elaraj DM, Khanafshar E et al. Tumor size predicts malignant potential in Hurthle cell neoplasms of the thyroid. World J. Surg. 2008; 32; 702-707.
9. Sugino K, Ito K, Mimura T, Kameyama K, Iwasaki H. Hurthle cell tumor of the thyroid: analysis of 188 cases. World J. Surg. 2001; 25; 1160-1163.
10. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch. Otolaryngol. Head Neck Surg. 2003; 129; 207-210.
11. Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol. Ital. 2009; 29; 305-311.
12. Goffredo P, Roman SA, Sosa JA. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancer 2013; 119; 504-511.
13. Maximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simoes M. The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr. Relat. Cancer 2012; 19; R131-R147.
14. Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 2006; 34; 330-334.
15. Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z. Does the fine-needle aspiration diagnosis of 'Hurthle-cell neoplasm/follicular neoplasm with oncocytic features' denote increased risk of malignancy? Diagn. Cytopathol. 2004; 31; 307-312.